Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Write for us
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • New for You
  • Covid-19
  • Video
  • Podcasts

Search Results for remdesivir

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir

With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and […]

COVID-19 Cases “Drastically’ Dropping in India Leading to Glut of Antivirals Remdesivir & Favipiravir
2 weeks ago
Share
4

Study Combines Korean Pancreatitis Drug Foistar with Remdesivir Targeting COVID-19

A Korean pharmaceutical company will combine its pancreatitis investigational product called Foistar (DWJ1248) with Gilead’s remdesivir in a new Phase […]

Study Combines Korean Pancreatitis Drug Foistar with Remdesivir Targeting COVID-19
3 weeks ago
Share
0

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

A growing number of articles, papers and discussions point out that despite the great news of vaccines approved for emergency […]

Movement in Canada Grows for COVID-19 Therapies as Nation Awaits Health Canada Decision on Favipiravir
3 weeks ago
Share
0

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients

Much attention was placed on the antiviral drug remdesivir during the early stages of the COVID-19 pandemic. In fact, considerable public […]

University of Cincinnati Study Raises Questions Associated with Use of Remdesivir in COVID-19 Patients
3 weeks ago
Share
0

NIAID’s ACTT-2: Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone: Triggered FDA EUA in Nov. 2020

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), recently produced results […]

NIAID’s ACTT-2 Hospitalized COVID-19 Patients Fare Better on Lilly’s Baricitinib & Remdesivir vs. Remdesivir Alone Triggered FDA EUA in Nov. 2020
3 weeks ago
Share
1

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir

This week, Eli Lilly and Company and Incyte announced the publication of the New England Journal of Medicine’s peer-reviewed results […]

Eli Lilly and Company and Incyte Announce Results of Phase 3 Study Using Baricitinib in Combination with Remdesivir
1 month ago
Share
1

World Health Organization Panel: Do Not Recommend Remdesivir for COVID-19 Patients Under Any Circumstances

The World Health Organization (WHO) advises against using Remdesivir under any circumstances. Apparently, a prominent group of intensive care doctors […]

World Health Organization Panel Do Not Recommend Remdesivir for COVID-19 Patients Under Any Circumstances
2 months ago
Share
0

Are Politics & Power Behind the Rise of Remdesivir?

In the early stages of the COVID-19 pandemic, those involved in monitoring new drugs that may help inhibit the SARS-CoV-2 […]

Are Politics & Power Behind the Rise of Remdesivir
3 months ago
Share
5

Will Remdesivir Become & Remain a Blockbuster? Listen to ‘The Fool’

Keith Speights writes for investment advisory website Motley Fool and brings the eclectic and varied background TrialSite appreciates. Mr. Speight highlighted […]

Will Remdesivir Become & Remain a Blockbuster Listen to ‘The Fool’
3 months ago
Share
0

UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®): Top Experts in Coronaviruses

Remdesivir has become a blockbuster drug in short time thanks in part to a pandemic-driven ACTIV-1 clinical trial and subsequent U.S. […]

UNC’s Baric Lab Key Contributor to Now Approved Remdesivir (Veklury®) Top Experts in Coronaviruses
3 months ago
Share
0

Posts navigation

Older posts

Trending News

  • Not Using Ivermectin, One Year In, Is Unethical And Immoral
    Not Using Ivermectin, One Year In, Is Unethical And Immoral
  • New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
    New York Supreme Court Judge Order: Give The Patient Ivermectin As Court Battle Leads to Ivermectin for Successful Treatment Against COVID-19
  • An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
    An Unlikely Nation Is Kicking This Pandemic. Guess Which. Then Why.
  • In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
    In Far-Flung Places, COVID-19 Is Being Treated Early And Well. Here’s Why Americans Don’t Know This.
  • Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert
    Unitaid, Part of the World Health Organization Funding Ivermectin Research Targeting COVID-19 led by British Expert

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.